Drug Profile
Research programme: ryanodine receptor calcium release channel modulators - Australian National University/Biotron
Alternative Names: Muscion projectLatest Information Update: 04 Feb 2011
Price :
$50
*
At a glance
- Originator Australian National University; Biotron
- Class Peptides; Small molecules
- Mechanism of Action Ryanodine receptor calcium release channel modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Heart failure
Most Recent Events
- 04 Feb 2011 No development reported for Heart failure in Australia (unspecified route)
- 27 Jun 2007 Early research in Heart failure in Australia (unspecified route)